Emilie Jouanjus

Toulouse, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Pharmacovigilance in the field of addiction: challenges and emerging solutions.

Pharmacovigilance in the field of addiction: challenges and emerging solutions.

Journal: Expert review of clinical pharmacology

Published: December 04, 2025

Cannabis and Cannabinoid-Related Suspected Adverse Drug Reactions: Global Patterns and Cross-National Analysis Based on VigiBase® Data.

Cannabis and Cannabinoid-Related Suspected Adverse Drug Reactions: Global Patterns and Cross-National Analysis Based on VigiBase® Data.

Journal: CNS drugs

Published: October 16, 2025

Cocaine use in Europe: the need for cross-sectoral collaboration between security, justice, health, and social systems.

Cocaine use in Europe: the need for cross-sectoral collaboration between security, justice, health, and social systems.

Journal: The Lancet. Public health

Published: September 17, 2025

High-dose use of pregabalin and gabapentin in France: a retrospective, population-based cohort study.

High-dose use of pregabalin and gabapentin in France: a retrospective, population-based cohort study.

Journal: The Lancet regional health. Europe

Published: February 19, 2025

French Addictovigilance monitoring of ketamine and its analogues.

French Addictovigilance monitoring of ketamine and its analogues.

Journal: The French journal of urology

Published: February 18, 2025

Comparative potential for generating spontaneous signals for abuse and dependence among drugs used for attention deficit hyperactivity disorder: A disproportionality analysis in VigiBase®.

Comparative potential for generating spontaneous signals for abuse and dependence among drugs used for attention deficit hyperactivity disorder: A disproportionality analysis in VigiBase®.

Journal: General psychiatry

Published: February 15, 2025

Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France.

Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France.

Journal: Fundamental & clinical pharmacology

Published: January 10, 2025

Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis.

Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis.

Journal: Heart (British Cardiac Society)

Published: November 16, 2024

The contribution of addictovigilance data to the French medical cannabis experimentation.

The contribution of addictovigilance data to the French medical cannabis experimentation.

Journal: Therapie

Published: July 30, 2024

From the first pilot initiatives in the early 1990s to the national OSIAP survey in the 2020s: More than 30years of insight in medication diversion phenomenon in France.

From the first pilot initiatives in the early 1990s to the national OSIAP survey in the 2020s: More than 30years of insight in medication diversion phenomenon in France.

Journal: Therapie

Published: July 23, 2024

Contribution of Addictovigilance data to assess adverse-events linked to psychoactive substances in children and adolescents.

Contribution of Addictovigilance data to assess adverse-events linked to psychoactive substances in children and adolescents.

Journal: British journal of clinical pharmacology

Published: June 14, 2024

Activities of clinical pharmacologists across Europe: A survey by the European association of clinical pharmacology and therapeutics.

Activities of clinical pharmacologists across Europe: A survey by the European association of clinical pharmacology and therapeutics.

Journal: European journal of clinical pharmacology

Published: December 23, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026